Phreesia, Inc. (PHR)
$
24.43
+1.13 (4.63%)
Key metrics
Financial statements
Free cash flow per share
0.2009
Market cap
1.5 Billion
Price to sales ratio
3.5338
Debt to equity
0.0672
Current ratio
1.7828
Income quality
-0.5507
Average inventory
0
ROE
-0.2287
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The total costs and expenses for the company are $381,317,000.00 reflecting its overall spending. The cost of revenue for the company is $134,934,000.00 showcasing its production and operational expenses. The financial data pertains to the fiscal year 2025. Furthermore, the company earned an interest income of $2,677,000.00 showcasing its financial investments. The income before tax ratio is -0.13 reflecting the pre-tax margin. The Phreesia Platform, which includes solutions for managing patient intake processes and integrated payment processing, is widely deployed through various modalities, including Phreesia Mobile, the Phreesia Dashboard, PhreesiaPads, and Arrivals Kiosks. Additionally, the platform offers robust features such as automated patient self-registration, revenue cycle solutions, appointment scheduling systems, and targeted life sciences marketing content. The platform also supports clinical data collection across multiple specialties, facilitating effective communication through surveys, messaging, and health campaigns. Notably, it introduces modules to manage COVID-19 related activities, signifying its adaptability to emerging healthcare needs. From an investment perspective, the stock is affordable at $24.43 suitable for budget-conscious investors. It is characterized by a low average trading volume of 536,569.00 indicating lower market activity. With a market capitalization of $1,452,600,471.00 the company is classified as a small-cap player. Phreesia is a key player in the healthcare technology industry, contributing significantly to the overall market landscape. Furthermore, it belongs to the Healthcare sector, driving innovation and growth within its field. The comprehensive suite of solutions and the strategic orientation of Phreesia underscore its pivotal role in enhancing patient engagement and revenue management in healthcare.
Is Phreesia, Inc. (PHR) a good investment?
Investing in Phreesia, Inc. (PHR) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as C, with a Bearish outlook. Always conduct your own research before investing.
What is Phreesia, Inc. (PHR)'s stock forecast?
Analysts predict Phreesia, Inc. stock to fluctuate between $17.07 (low) and $30.53 (high) in the next 365 days, reflecting market expectations and potential volatility.
What is Phreesia, Inc.'s market capitalization?
As of 2025-05-29, Phreesia, Inc.'s market cap is $1,452,600,471, based on 59,459,700 outstanding shares.
How does Phreesia, Inc. compare to competitors like Meta Platforms, Inc. Class A Common Stock?
Compared to Meta Platforms, Inc. Class A Common Stock, Phreesia, Inc. has a Lower Market-Cap, indicating a difference in performance.
How can I buy Phreesia, Inc. (PHR) stock?
To buy Phreesia, Inc. (PHR) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for PHR. Place an order (Market, Limit, etc.).
What is the best time to invest in Phreesia, Inc.?
The best time to invest depends on market trends and technical indicators, which show a Bearish trend based on economic conditions and company performance.
How did Phreesia, Inc. perform in the last earnings report?
Revenue: $419,813,000 | EPS: -$1.02 | Growth: -59.36%.
Where can I find Phreesia, Inc.'s investor relations reports?
Visit https://www.phreesia.com/investor-relations for detailed financial reports.
Where can I find historical stock prices for Phreesia, Inc.?
You can explore historical data from here
What is the all-time high and low for Phreesia, Inc. stock?
All-time high: $81.59 (2021-02-10) | All-time low: $12.05 (2023-10-30).
What are the key trends affecting Phreesia, Inc. stock?
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
seekingalpha.com
Phreesia, Inc. (NYSE:PHR ) Q1 2026 Earnings Conference Call May 28, 2025 8:30 AM ET Company Participants Balaji Gandhi - CFO Chaim Indig - CEO Conference Call Participants Anne Samuel - JPMorgan Jailendra Singh - Truist Securities Jessica Tassan - Piper Sandler Richard Close - Canaccord Genuity John Ransom - Raymond James Daniel Grosslight - Citi William Jellison - D.A. Davidson Ryan MacDonald - Needham & Company Jeff Garro - Stephens Scott Schoenhaus - Keybank Jared Hass - William Blair Aaron Kempson - Citizens JMP Gene Mannheimer - Freedom Capital Markets Joe Vruwink - Baird Operator Good morning, ladies and gentlemen.
zacks.com
The headline numbers for Phreesia (PHR) give insight into how the company performed in the quarter ended April 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
zacks.com
Phreesia (PHR) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to loss of $0.35 per share a year ago.
businesswire.com
ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia will release its fiscal first quarter 2026 financial results after the close of market trading on Wednesday, May 28, 2025.
zacks.com
The consensus price target hints at a 28% upside potential for Phreesia (PHR). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
seekingalpha.com
Phreesia remains resilient, maintaining guidance and showing strong financial performance, with Q4 revenue growth of 15% year-over-year and improved cash flow. Despite a slight deceleration in customer growth, Phreesia's revenue per healthcare services client increased, driven by network solutions, and the company expects 13.6% revenue growth in fiscal 2026. Future growth drivers include patient education initiatives and Post-Script Engagement, while competition is seen as beneficial, enhancing market awareness and adoption of healthcare solutions.
seekingalpha.com
Phreesia, Inc. (NYSE:PHR ) Q4 2025 Earnings Conference Call March 12, 2025 5:00 PM ET Company Participants Balaji Gandhi - CFO Chaim Indig - Co-Founder, CEO & Director Conference Call Participants Anne Samuel - JPMorgan Jessica Tassan - Piper Sandler Jailendra Singh - Triust Securities Ryan Daniels - William Blair Richard Close - Canaccord Genuity Ryan MacDonald - Needham & Company Jeff Garro - Stephens Daniel Grosslight - Citi Group Scott Schoenhaus - KeyBanc Capital Markets Operator Good evening, ladies and gentlemen, and welcome to Phreesia's Fourth Quarter Fiscal 2025 Earnings Conference Call. [Operator Instructions] First, I would like to introduce Balaji Gandhi, Phreesia's Chief Financial Officer.
zacks.com
Phreesia (PHR) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of $0.19. This compares to loss of $0.56 per share a year ago.
zacks.com
Phreesia (PHR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
See all news
